129 related articles for article (PubMed ID: 38307573)
21. Prognostic significance of the preoperative C-reactive protein-albumin-lymphocyte (CALLY) index on outcomes after gastrectomy for gastric cancer.
Fukushima N; Masuda T; Tsuboi K; Takahashi K; Yuda M; Fujisaki M; Ikegami T; Yano F; Eto K
Surg Today; 2024 Mar; ():. PubMed ID: 38491233
[TBL] [Abstract][Full Text] [Related]
22. The Clinical Impact of the Pretreatment Albumin to Fibrinogen Ratio in Esophageal Cancer Patients Who Receive Curative Treatment.
Aoyama T; Maezawa Y; Hashimoto I; Hara K; Kazama K; Komori K; Kato A; Otani K; Tamagawa A; Cho H; Morita J; Kawahara S; Tanabe M; Oshima T; Saito A; Yukawa N; Rino Y
In Vivo; 2024; 38(3):1253-1259. PubMed ID: 38688590
[TBL] [Abstract][Full Text] [Related]
23. The impact of C-reactive protein-albumin-lymphocyte (CALLY) index on the prognosis of patients with distal cholangiocarcinoma following pancreaticoduodenectomy.
Tsunematsu M; Haruki K; Taniai T; Tanji Y; Shirai Y; Furukawa K; Uwagawa T; Onda S; Yanagaki M; Usuba T; Nakabayashi Y; Okamoto T; Ikegami T
Ann Gastroenterol Surg; 2023 May; 7(3):503-511. PubMed ID: 37152771
[TBL] [Abstract][Full Text] [Related]
24. Clinical Impact of Preoperative Albumin-Bilirubin Status in Esophageal Cancer Patients Who Receive Curative Treatment.
Aoyama T; Ju M; Machida D; Komori K; Tamagawa H; Tamagawa A; Maezawa Y; Kano K; Hara K; Segami K; Hashimoto I; Nagasawa S; Nakazono M; Oshima T; Yukawa N; Rino Y
In Vivo; 2022; 36(3):1424-1431. PubMed ID: 35478112
[TBL] [Abstract][Full Text] [Related]
25. The Systemic Inflammation Score Is an Independent Prognostic Factor for Esophageal Cancer Patients who Receive Curative Treatment.
Aoyama T; Ju M; Komori K; Tamagawa H; Tamagawa A; Maezawa Y; Hashimoto I; Kano K; Hara K; Cho H; Segami K; Machida D; Nakazono M; Oshima T; Yukawa N; Rino Y
Anticancer Res; 2022 May; 42(5):2711-2717. PubMed ID: 35489731
[TBL] [Abstract][Full Text] [Related]
26. Clinical feasibility of the preoperative C-reactive protein-albumin-lymphocyte index to predict short- and long-term outcomes of patients with gastric cancer.
Okugawa Y; Ohi M; Kitajima T; Higashi K; Sato Y; Yamashita S; Uratani R; Shimura T; Imaoka H; Kawamura M; Koike Y; Yasuda H; Yoshiyama S; Okita Y; Toiyama Y
J Gastrointest Surg; 2024 Apr; ():. PubMed ID: 38641163
[TBL] [Abstract][Full Text] [Related]
27. Immunonutritive Scoring for Patients with Hepatocellular Carcinoma Undergoing Transarterial Chemoembolization: Evaluation of the CALLY Index.
Müller L; Hahn F; Mähringer-Kunz A; Stoehr F; Gairing SJ; Michel M; Foerster F; Weinmann A; Galle PR; Mittler J; Pinto Dos Santos D; Pitton MB; Düber C; Kloeckner R
Cancers (Basel); 2021 Oct; 13(19):. PubMed ID: 34638502
[TBL] [Abstract][Full Text] [Related]
28. Geriatric Nutritional Risk Index Is an Independent Prognostic Factor for Patients With Esophageal Cancer Who Receive Curative Treatment.
Kato A; Aoyama T; Maezawa Y; Hashimoto I; Hara K; Kazama K; Numata M; Sawazaki S; Tamagawa A; Cho H; Morita J; Tanabe M; Kamiya N; Tamagawa H; Otani K; Kawahara S; Oshima T; Yukawa N; Saito A; Rino Y
Anticancer Res; 2024 Jan; 44(1):331-337. PubMed ID: 38159974
[TBL] [Abstract][Full Text] [Related]
29. The Prognostic Immune and Nutritional Indices Are Independent Prognostic Factors for Esophageal Cancer Patients Who Receive Curative Treatment.
Aoyama T; Hashimoto I; Maezawa Y; Hara K; Kato A; Kazama K; Tamagawa A; Cho H; Nakazono M; Numata M; Kawahara S; Oshima T; Saito A; Yukawa N
Anticancer Res; 2024 May; 44(5):2185-2192. PubMed ID: 38677744
[TBL] [Abstract][Full Text] [Related]
30. Prognostic value of inflammatory markers for detecting anastomotic leakage after esophageal resection.
Liesenfeld LF; Sauer P; Diener MK; Hinz U; Schmidt T; Müller-Stich BP; Hackert T; Büchler MW; Schaible A
BMC Surg; 2020 Dec; 20(1):324. PubMed ID: 33298038
[TBL] [Abstract][Full Text] [Related]
31. Influence of the Preoperative C-Reactive Protein-to-Albumin Ratio on Survival and Recurrence in Patients With Esophageal Cancer.
Tamagawa H; Aoyama T; Tamagawa A; Komori K; Maezawa Y; Kano K; Murakawa M; Atsumi Y; Hara K; Kazama K; Numata M; Oshima T; Yukawa N; Masuda M; Rino Y
Anticancer Res; 2020 Apr; 40(4):2365-2371. PubMed ID: 32234939
[TBL] [Abstract][Full Text] [Related]
32. Prognostic Significance of Postoperative Complications After Curative Resection for Patients With Esophageal Squamous Cell Carcinoma.
Saeki H; Tsutsumi S; Tajiri H; Yukaya T; Tsutsumi R; Nishimura S; Nakaji Y; Kudou K; Akiyama S; Kasagi Y; Nakanishi R; Nakashima Y; Sugiyama M; Ohgaki K; Sonoda H; Oki E; Maehara Y
Ann Surg; 2017 Mar; 265(3):527-533. PubMed ID: 28169928
[TBL] [Abstract][Full Text] [Related]
33. The Preoperative Neutrophil-To-Lymphocyte Ratio Is a Novel Immune Parameter for the Prognosis of Esophageal Basaloid Squamous Cell Carcinoma.
Xiao Q; Zhang B; Deng X; Wu J; Wang H; Wang Y; Wang W
PLoS One; 2016; 11(12):e0168299. PubMed ID: 27959959
[TBL] [Abstract][Full Text] [Related]
34. Impact of inflammation-based prognostic score on survival after curative thoracoscopic esophagectomy for esophageal cancer.
Hirahara N; Matsubara T; Hayashi H; Takai K; Fujii Y; Tajima Y
Eur J Surg Oncol; 2015 Oct; 41(10):1308-15. PubMed ID: 26235238
[TBL] [Abstract][Full Text] [Related]
35. The impact of geriatric nutritional risk index on surgical outcomes after esophagectomy in patients with esophageal cancer.
Kubo N; Sakurai K; Tamura T; Toyokawa T; Tanaka H; Muguruma K; Yashiro M; Ohira M
Esophagus; 2019 Apr; 16(2):147-154. PubMed ID: 30311102
[TBL] [Abstract][Full Text] [Related]
36. A Novel Inflammation-Based Prognostic Score: The Fibrinogen/Albumin Ratio Predicts Prognoses of Patients after Curative Resection for Hepatocellular Carcinoma.
Xu Q; Yan Y; Gu S; Mao K; Zhang J; Huang P; Zhou Z; Chen Z; Zheng S; Liang J; Lin Z; Wang J; Yan J; Xiao Z
J Immunol Res; 2018; 2018():4925498. PubMed ID: 30027102
[TBL] [Abstract][Full Text] [Related]
37. The clinical impacts of lymphocyte-to-C-reactive protein ratio for esophageal cancer patients who receive curative treatment.
Aoyama T; Nagasawa S; Nakazono M; Segami K; Tamagawa H; Tamagawa A; Hara K; Oshima T; Yukawa N; Masuda M; Rino Y
J Cancer Res Ther; 2023; 19(3):556-561. PubMed ID: 37470574
[TBL] [Abstract][Full Text] [Related]
38. Prognostic Significance of Inflammatory and Nutritional Parameters in Patients with Esophageal Cancer.
Miyazaki T; Sakai M; Sohda M; Tanaka N; Yokobori T; Motegi Y; Nakajima M; Fukuchi M; Kato H; Kuwano H
Anticancer Res; 2016 Dec; 36(12):6557-6562. PubMed ID: 27919983
[TBL] [Abstract][Full Text] [Related]
39. Preoperative maximal voluntary ventilation, hemoglobin, albumin, lymphocytes and platelets predict postoperative survival in esophageal squamous cell carcinoma.
Hu SJ; Zhao XK; Song X; Lei LL; Han WL; Xu RH; Wang R; Zhou FY; Wang L; Wang LD
World J Gastroenterol; 2021 Jan; 27(4):321-335. PubMed ID: 33584065
[TBL] [Abstract][Full Text] [Related]
40. Albumin and Neutrophil-to-Lymphocyte Ratio Score in Neoadjuvant Concurrent Chemoradiotherapy for Esophageal Cancer: Comparison With Prognostic Nutritional Index.
Hsueh WH; Hsueh SW; Yeh KY; Hung YS; Ho MM; Lin SY; Tseng CK; Hung CY; Chou WC
In Vivo; 2022; 36(5):2400-2408. PubMed ID: 36099141
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]